Table 1. Demographic, immunologic and virologic characteristics of the study population n = 120.
| Characteristic | N = 120 | |
|---|---|---|
| Gender | Female | 21 (17.5%) |
| Male | 98 (81.7%) | |
| Transgender | 1 (0.8%) | |
| Ethnicity | White | 46 (8.37%) |
| African American | 33 (27.5%) | |
| Hispanic / Latino | 30 (25%) | |
| Other (Asian, Natives) | 11 (9.2%) | |
| Age | Median (range) | 44 (20–64) |
| On HAART | Yes | 97 (81%) |
| CD4 count (cells/mm3) | <200 | 22 (18%) |
| >200 | 98 (82%) | |
| Viral Load (copies/ml) | <50 | 82 (68.3%) |
| >50 | 38 (31.7%) | |
| Patients on HAART | Viral Load < 50 | 79 (81.5%) |
| Viral Load >50 | 18 (18.5%) | |
| CD4 count < 200 | 17 (17.5%) | |
| CD4 count > 200 | 80 (82.5%) | |
| Patients not currently on HAART | Viral Load < 50 | 3 (13%) |
| Viral Load >50 | 20 (87%) | |
| CD4 count < 200 | 5 (12%) | |
| CD4 count > 200 | 18 (78%) |